The pompe disease treatment market is anticipated to reach USD 1,409.09 Million by 2030 at 3.80% CAGR during the forecast period 2022-2030. The lack of mutation of the GAA gene causes glycogen buildup, which triggers heart problems, muscular weakness, and liver damage, all of which can lead to early mortality in newborns is increasingly being detected. Due to various massive government...